Eli Lilly's weight-loss drug helps nearly 99% of patients remain diabetes-free
Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of weekly injections. The results suggest that tirzepatide - the active ingredient in Lilly's diabetes drug Mounjaro and weight-loss treatment Zepbound - could prevent one new case of diabetes for every nine patients treated.
Zepbound Cuts the Risk of Progressing to Diabetes by 94%, Eli Lilly Data Shows
Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new results from a three-year trial.
Eli Lilly Say Most Tirzepatide Users Remained Diabetes-Free at 176 Weeks
Eli Lilly said new results from a Phase 3 study of its tirzepatide showed weekly injections in adults with pre-diabetes and obesity or overweight resulted in sustained weight loss, with nearly 99% remaining diabetes-free at 176 weeks.
Lilly reports trial results of tirzepatide for treating obesity and pre-diabetes
Eli Lilly has reported comprehensive outcomes from the SURMOUNT-1 study of tirzepatide (Zepbound and Mounjaro) for treating pre-diabetic and obese individuals. Spanning 176 weeks of treatment, the Phase III trial evaluated the efficacy and safety of tirzepatide in adults without type 2 diabetes (T2D) who were either obese or overweight with complications such as cardiovascular disease,
Diabetes medication may be effective in helping people drink less alcohol, research finds
New research, led by experts at the University of Nottingham, has found that certain types of medication used to treat ...
News Medical on MSN1h
Diabetes medication shows promise in reducing alcohol use
New research, led by experts at the University of Nottingham, has found that certain types of medication used to treat diabetes may be effective in reducing alcohol use.
New over-the-counter device could help Type 2 diabetics get off medication
The University of Pittsburgh is studying ways to improve the lives of Type 2 diabetics, or people who just want to control their sugar levels.
New weight loss drug decreases appetite without nausea — and can even burn calories
Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...
News Medical on MSN1d
Scientists discover new breakthrough in weight loss and diabetes treatment
Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...
Diabetes.co.uk7d
New treatment to transform type 1 diabetes care
A newly designed therapy following an islet cell transplant could mean people with type 1 diabetes no longer need to inject ...
New guidelines for treatment of Type 2 diabetes from International Diabetes Federation soon
IDF creating new Type 2 diabetes guidelines with global experts, focusing on patient-centered care and global accessibility.
New weight loss drug better than Ozempic, without causing nausea?
Researchers at the University of Copenhagen have developed a new weight-loss drug that may surpass the effectiveness of ...
More than 800 million people worldwide have diabetes
Fourteen percent of the world's people -- more than 800 million -- now have diabetes, a doubling of the global rate for the ...
Interaksyon on MSN10h
Over 800m adults have diabetes globally, with many 'not receiving treatment'
A new study found that over 800 million adults have diabetes worldwide — almost twice as many as previous estimates have ...
Knowridge10h
New diabetes drug shows promise in preventing kidney and lung disease
A recent study from the University of Hong Kong has found that sodium-glucose cotransporter 2 inhibitors (SGLT2i), a new type ...